Skip to Menu Skip to Content

As a pharmaceutical company, you may have uncertainties around the process of the United Kingdom leaving the European Union. With an international network of Life Sciences labs located throughout North America, Europe and Asia, SGS is here to help.

Dropping blue substance into test tubes from pipette

SGS offers a full range of integrated solutions – from preclinical activities to Phase I-IV trials, bioanalytical, R&D, characterization, biosafety, and quality control testing of small and large molecules, raw material products and containers. Whether your manufacturing stays in the UK or moves to another site, we have the capabilities and capacity to ensure that you are ready – no matter the outcome of the Brexit deal.

SGS service highlights

SGS life sciences solutions offer you:

  • Lot release testing, including analytical chemistry and microbiology
  • Method development and validation
  • Stability studies
  • Extractables and leachables
  • Biopharmaceutical characterization
  • Potency assays
  • Bioanalysis of large and small molecules
  • Impurity determination
  • Equipment and IT validation

Laboratories near you

Our global laboratory network provides a local presence in:

  • Belgium
  • France
  • Germany
  • Greece
  • Italy
  • Scotland
  • Switzerland

Discover how SGS can help you post-Brexit – contact us today

To find out more about SGS Life Sciences services and post-Brexit testing, fill out the form below:

Fields marked with an asterisk (*) are mandatory.